Literature DB >> 29217027

Optic disc hemorrhages in glaucoma and common clinical features.

Zeynep Kayaarasi Ozturker1, Kristen Munro2, Neeru Gupta3.   

Abstract

OBJECTIVE: To analyze optic nerve head stereophotographs for the presence of optic disc hemorrhages, and to describe bleeding patterns and patient characteristics.
DESIGN: Retrospective, cross-sectional study. PARTICIPANTS: 1113 optic nerve stereophotograph pairs of 562 consecutive patients.
METHODS: Stereophotographs were systematically reviewed for the presence of a disc hemorrhage with careful documentation of optic nerve head features. All charts of patients with hemorrhage were subsequently studied for demographic information and clinical data.
RESULTS: Disc hemorrhages were observed in 7.1% of patients with optic disc photography. Most patients had open-angle glaucoma (57.5%) with focal ischemic phenotype of the optic disc (66.7%). The mean vertical and horizontal cup-disc ratios were 0.82 ± 0.14 and 0.76 ± 0.14, respectively. The β-zone peripapillary atrophy was observed in 48.9% of patients. The most common location was the inferotemporal region of the disc (60.8%), and most were flame or splinter shaped (70.6%). Disc hemorrhages were found either superficial to or within the retinal nerve fibre layer (72.5%), and in association with a notch (64.4%). The average intraocular pressure was 17.3 ± 4.9 mm Hg, and most hemorrhages were associated with early visual field defects (42.5%).
CONCLUSIONS: Optic disc hemorrhages in patients with glaucoma were most frequently observed inferiorly in association with a notch. Most eyes with a disc hemorrhage had an intraocular pressure within normal range and had either early or no visual field loss. These findings highlight the importance of careful examination of the optic nerve head to look for the presence of a disc hemorrhage as an important biomarker of glaucoma damage.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29217027     DOI: 10.1016/j.jcjo.2017.04.011

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  6 in total

1.  Association between Rates of Retinal Nerve Fiber Layer Thinning after Intraocular Pressure-Lowering Procedures and Disc Hemorrhage.

Authors:  Huiyuan Hou; Sasan Moghimi; Linda M Zangwill; James A Proudfoot; Tadamichi Akagi; Takuhei Shoji; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb
Journal:  Ophthalmol Glaucoma       Date:  2019-11-14

2.  Clinical characteristics of glaucoma patients with disc hemorrhage in different locations.

Authors:  Yun Hsia; Chien-Chia Su; Tsing-Hong Wang; Jehn-Yu Huang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-06-13       Impact factor: 3.117

3.  The impact of disc hemorrhage studies on our understanding of glaucoma: a systematic review 50 years after the rediscovery of disc hemorrhage.

Authors:  Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2018-11-21       Impact factor: 2.447

4.  Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study.

Authors:  Clara C Cousins; Billy X Pan; Jonathan C Chou; Lucy Q Shen; Mae O Gordon; Michael A Kass; Robert Ritch; Louis R Pasquale
Journal:  Am J Ophthalmol       Date:  2020-04-23       Impact factor: 5.488

5.  Lamina Cribrosa Capillaries Straighten as Intraocular Pressure Increases.

Authors:  Bryn L Brazile; Bin Yang; Susannah Waxman; Po Lam; Andrew P Voorhees; Yi Hua; Ralitsa T Loewen; Nils A Loewen; Joseph F Rizzo; Tatjana Jakobs; Ian A Sigal
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

6.  Disc Hemorrhages Are Associated With Localized Three-Dimensional Neuroretinal Rim Thickness Progression in Open-Angle Glaucoma.

Authors:  Milica A Margeta; Kitiya Ratanawongphaibul; Edem Tsikata; Michele Zemplenyi; Courtney L Ondeck; Janice Kim; Anne L Coleman; Fei Yu; Johannes F de Boer; Teresa C Chen
Journal:  Am J Ophthalmol       Date:  2021-06-29       Impact factor: 5.258

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.